A potentially severe acute respiratory infection caused by the novel coronavirus severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2).[1] The clinical presentation is generally that of a respiratory infection
with a symptom severity ranging from a mild common cold-like illness, to a severe viral ...
Betacoronavirus/patogenicidad,
Infecciones por Coronavirus/diagnóstico por imagen,
Infecciones por Coronavirus/complicaciones,
Infecciones por Coronavirus/tratamiento farmacológico,
Neumonía Viral/diagnóstico por imagen,
Neumonía Viral/tratamiento farmacológico,
Neumonía Viral/complicaciones,
Pandemias/estadística & datos numéricos,
Brote de los Síntomas,
Grupos de Riesgo,
China/epidemiología,
Neumonía Asociada a la Atención Médica/diagnóstico,
Personal de Salud/organización & administración,
Portador Sano/transmisión,
Transmisión Vertical de Enfermedad Infecciosa/prevención & control
China has managed to control the coronavirus disease (COVID-19) with confinement measurements and treatment strategies, while other countries are struggling to contain the spread. This study discussesthe guidelines related to COVID-19 in China in order to provide important references for other countries
...
Betacoronavirus/efectos de los fármacos,
Neumonía Viral/epidemiología,
Infecciones por Coronavirus/epidemiología,
China/epidemiología,
Pandemias/prevención & control,
Pandemias/estadística & datos numéricos,
Monitoreo Epidemiológico,
Gestión de la Información en Salud/métodos,
Interferones/uso terapéutico,
Lopinavir/uso terapéutico,
Ritonavir/uso terapéutico,
Ribavirina/uso terapéutico,
Cloroquina/uso terapéutico,
Infecciones por Coronavirus/tratamiento farmacológico,
Neumonía Viral/tratamiento farmacológico
Bhimraj, Adarsh;
Morgan, Rebecca L;
Shumaker, Amy Hirsch;
Lavergne, Valery;
Baden, Lindsey;
Cheng, Vincent Chi-Chung;
Edwards, Kathryn M;
Gandhi, Rajesh;
Muller, William J;
O’Horo, John C;
Shoham, Shmuel;
Murad, M. Hassan;
Mustafa, Reem A;
Sultan, Shahnaz;
Falck-Ytter, Yngve.
Develop evidence-based rapid guidelines intended to support patients, clinicians and other health-care professionals in their decisions about treatment and management of patients with COVID-19....
The purpose of this guideline is to ensure the best treatment for adults with suspected or confirmed pneumonia in the community during the COVID-19 pandemic and best use of NHS resources. We have withdrawn our guideline on diagnosing and managing pneumonia in adults until further notice....
This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...
Diagnóstico Clínico/diagnóstico,
Betacoronavirus/efectos de los fármacos,
Infecciones por Coronavirus/diagnóstico,
Neumonía Viral/diagnóstico,
Hipoxia/diagnóstico,
Gravedad del Paciente,
Infecciones por Coronavirus/tratamiento farmacológico,
Neumonía Viral/tratamiento farmacológico,
Dexametasona/uso terapéutico,
Lactancia Materna,
Antivirales/uso terapéutico,
Hidroxicloroquina/uso terapéutico,
Colchicina/uso terapéutico,
Plasma/inmunología,
Darunavir/uso terapéutico,
Interferones/uso terapéutico,
Práctica Clínica Basada en la Evidencia/métodos